ASCO guidelines
Jump to navigation
Jump to search
This page will be a gathering place for the American Society of Clinical Oncology (ASCO) guidelines that do not clearly fit under a disease-specific page. This link will take you to the landing page for all ASCO Guidelines, Tools, & Resources.
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
Bone-modifying agents
- 2022: Eisen et al. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update PubMed
- 2017: Dhesy-Thind et al. Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline PubMed
- 2003: Hillner et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer PubMed
- 2000: Hillner et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer: American Society of Clinical Oncology Bisphosphonates Expert Panel PubMed
- 2017: Van Poznak et al. Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update PubMed
- 2002: Berenson et al. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma PubMed
Cancer cachexia
- 2023: Roeland et al. Cancer Cachexia: ASCO Guideline Rapid Recommendation Update PubMed
- 2020: Roeland et al. Management of Cancer Cachexia: ASCO Guideline PubMed
Chemotherapy-induced peripheral neuropathy
- 2020: Loprinzi et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update PubMed
Dyspnea
- 2021: Hui et al. Management of Dyspnea in Advanced Cancer: ASCO Guideline PubMed
Genetic and genomic testing
- 2022: Chakravarty et al. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion PubMed
- 2016: Allegra et al. Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 PubMed
- 2011: Keedy et al. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy PubMed
Infectious diseases
- 2020: Hwang et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update PubMed
- 2015: Hwang et al. Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update PubMed
- 2010: Artz et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases PubMed
- 2018: Taplitz et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update PubMed
Obesity
- 2021: Griggs et al. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update PubMed
Pain
- 2023: Paice et al. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline PubMed
Palliative care
- 2017: Ferrell et al. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update PubMed